Podcast appearances and mentions of Paul Armentano

Text Cannabis Man!In this milestone episode of the Cannabis Man Podcast, host Don Kleppin celebrates the show's incredible reach across all 50 states and 85 countries, along with its recognition as the #1 indie news podcast on GoodPods. Don reflects on the global progress of cannabis legalization and shares the latest Illinois sales figures, upcoming Best In Grass Awards, and product reviews, including SweetBuzz's Sweet Sparks and Tales & Travels' Grandi Guava flower.This week's guest is Paul Armentano, Deputy Director of NORML, who joins Don to discuss the DEA's rescheduling timeline, the latest FBI cannabis arrest numbers, Florida's legalization ballot initiative, and more. Don also covers national cannabis news, including a Florida prosecutor's stance on Amendment 3 and Republican VP nominee JD Vance's remarks on fentanyl-laced cannabis. Plus, hear a fun story about Snoop Dogg's personal "chaperone."To start earning points on cannabis purchases download the High Rewards app and use the promo code CANNMAN for 5$! Rate and review the show, and share thoughts via text on cannabis products and topics. Subscribe to the Weekly Chronic newsletter for more!Support the showThanks for listening!Follow the show on Facebook, YouTube, Twitter and Instagram!Get points at dispos with High Rewards! Use Promo Code: CannManInterested in advertising? Email host@cannabismanpodcast.com!Thinking of starting a podcast? Host with Buzzsprout!

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Kris Krane are back to sit down with Paul Armentano, Deputy Director of NORML. Paul joined our hosts this week to talk about his career of advocacy work within the cannabis space and to highlight the positives and shortcomings with the DEA's proposed move to reschedule cannabis. Paul walked us through his thoughts, which can also be found in his recent op-ed in the Orange County Register, as well as what he thinks will move the needle through the DEA open comment period.  Kris and Paul also dive into the debate of incrementalism vs full reform for cannabis as well as why it's critical to ensure advocacy organizations like NORML stay funded and operational, even as the U.S. becomes more accepting of cannabis.   If you are interested in learning more about Paul or how to get more involved in NORML's work, visit the links in our show notes. Also, be sure to follow NORML, as well as the organization's local chapters, across all social platforms. So, sit back and enjoy our conversation with Paul Armentano of NORML. Links, mentions, and socials: NORML Website: https://norml.org/marijuana  NORML Instagram: https://www.instagram.com/natlnorml  NORML News: https://norml.org/subscribe  Paul's Appearance on The Disagreement: https://thedisagreement.substack.com/p/episode-7-marijuana-legalization Paul's review on scientific literature around cannabis and cannabinoids: https://www.amazon.com/Clinical-Applications-Cannabis-Cannabinoids-Scientific-ebook/dp/B09KSTZPDJ NORML on recent medical marijuana research: https://norml.org/marijuana/library/recent-medical-marijuana-research/ Recent bylines from Paul: https://otherwords.org/authors/paul-armentano/  Paul's OC Register byline: https://www.ocregister.com/2024/05/14/the-beginning-of-the-end-of-cannabis-prohibition/  Show Credits: This episode was hosted by Anne Donohoe and Kris Krane of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week's episode is a crossover roundtable event with our friends at the Multidisciplinary Association for Psychedelic Studies (MAPS) covering the DEA's proposed rescheduling of cannabis from Schedule I to a Schedule III drug. Hosted by our very own Anne Donohoe, the Q&A discussion also features Betty Aldworth, Director of Communications & Post-Prohibition Strategy at MAPS, Karen O'Keefe, Director of State Policies at Marijuana Policy Project (MPP) and Paul Armentano, Deputy Director at NORML.  With the unprecedented federal drug policy change on the near horizon, MAPS assembled leaders with more than 50 years of combined experience in the cannabis policy reform movement to talk about what these changes are, why they matter, what myths need debunking, and what still needs to be done. Some of the topics covered in this conversation include the impact rescheduling will have on research and development of cannabis-based medicines, criminal law and systems-impacted people, cannabis banking and interstate commerce and veteran affairs.  If you are interested in learning more about how MAPS, MPP or NORML have played pivotal roles in implementing drug policy reform over the decades, be sure to follow them all on their socials linked in our show notes and visit their websites to follow their advocacy work.   So, sit back and enjoy this crossover Q&A discussion on the future of cannabis drug policy.  Links and mentions in the show https://maps.org/  https://norml.org/  https://www.mpp.org/  Links to the guest's company and social media accounts Betty Aldworth LinkedIn: https://www.linkedin.com/in/bettyaldworth/  Karen O'Keefe LinkedIn: https://www.linkedin.com/in/karen-o-keefe-255a9921a/  NORML LinkedIn: https://www.linkedin.com/company/norml/  MPP Twitter: https://twitter.com/marijuanapolicy  NORML Twitter: https://twitter.com/NORML  MAPS Twitter: https://twitter.com/maps  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther and to the MAPS team.  You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: linkedin.com/company/thegreenrushpodcast

Dive into a compelling dialogue with NORML's Deputy Director, Paul Armentano, as we dissect the journey of legal cannabis initiatives in Congress. From the '90s draconian proposals by Newt Gingrich to today's more enlightened stance, we unpack the evolving narrative. Paul debunks certain media myths comparing potential harm from smoking cannabis to smoking tobacco, shedding light on some lesser-known facts. I also share my minty escapade with Kush Mints flower from FloraCal Farms, and in our Illinois News Joint Wrap, unveil upcoming cannabis events and policy changes in Illinois. We conclude with a striking study on traffic death rates in cannabis-legal states. Hit play for a blend of historical insights, current analysis, and a sprinkle of cannabis culture. Make sure to subscribe and catch every enlightening episode of the Cannabis Man Podcast!Support the showFollow the show on Facebook, YouTube, Twitter and Instagram!Looking for cannabis products? Head to 420 pipes and use the promo code: CANNABISMAN for 10 percent off your order! Blaze on!

How does marijuana affect driving? Can one learn to drive safely while high? Are there reliable tests for detecting marijuana-impaired driving? How accurate are simulator tests of people driving under the influence of marijuana? Why do marijuana users tend to think they're driving worse than they actually are? Has marijuana legalization resulted in more motor vehicle accidents and deaths? How are laws changing in this area? No one is more knowledgeable or thoughtful about these questions than Paul Armentano, NORML's expert on all things marijuana for almost thirty years.See omnystudio.com/listener for privacy information.

Una nueva encuesta muestra hasta qué punto los estadounidenses han dejado de temer a la marihuana.La mayoría de los encuestados informó que consideran que el alcohol es más dañino que la marihuana, lo que indica cuánto han evolucionado las percepciones en torno a la planta en Estados Unidos.La encuesta, realizada por la empresa de investigación de mercado SSRS, mostró que más de la mitad de los encuestados (58 por ciento) creen que el cannabis es más seguro que el alcohol. Millennials, Gen Z, Gen X y Boomers, en ese orden, señalaron que piensan que el cannabis es menos riesgoso que el alcohol.Una mirada más profunda a los resultados muestra que estos están en línea con lo que han demostrado las encuestas anteriores sobre marihuana o cannabis: la gran mayoría de los estadounidenses cree en la marihuana medicinal legal (92 por ciento) y otro porcentaje cree en la marihuana para uso lúdico (69 por ciento).Si bien las políticas nacionales siguen siendo lentas para adoptar el cambio, con cada año que pasa, las personas en los EE. UU. continúan acostumbrándose a la marihuana.Al comentar sobre los resultados de la encuesta, Paul Armentano, subdirector de la Organización Nacional para la Reforma de las Leyes sobre la Marihuana en Estados Unidos, señaló en un comunicado que: los votantes apoyan la legalización de la marihuana independientemente de la afiliación a un partido político.Armentano continuó diciendo: “En un momento en que la política nacional sigue estando muy polarizada, los funcionarios electos deberían unirse de manera bipartidista para derogar la política fallida de prohibición del cannabis. Es una de las pocas reformas políticas en las que los votantes de derecha e izquierda pueden estar de acuerdo, reportó The GrowthOp.ADEMÁSEn general, el contenido de CBD de los productoontaminantes preocupan a la industria del CannabisUn nuevo informe analítico ha demostrado que, a medida que la popularidad de los productos de CBD continúa aumentando, muchas empresas están siendo objeto de un mayor escrutinio por negligencia relacionada con sus prácticas de prueba de pureza.Esto es según los datos recopilados por la firma de análisis con sede en Israel Leafreport publicados el 25 de mayo de 2022, encontraron que el 20 por ciento de las marcas de cannabis no están realizando ninguna prueba de pureza en sus productos, y solo el 7 por ciento de ellos están probando toda su selección para detectar contaminación.s de cannabis tiende a diferir de lo que figura en la etiqueta en aproximadamente un 25 por ciento.El informe examinó aproximadamente 4 mil 400 productos de 188 marcas que producen productos con infusión de CBD para poder evaluar con precisión el nivel de transparencia y marketing honesto presente en la industria. Las marcas probadas incluyen NuLeaf Naturals, Green Roads CBD, High Falls Hemp, entre otras.Algunos datos del informe:El 28 por ciento de los distribuidores optó por no realizar ninguna prueba de pesticidas.El 26 por ciento se olvidó de determinar si había metales pesados ​​presentes en sus productos.El 24 por ciento no se molestó en probar microbios como bacterias.//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////España es el centro de cultivo de marihuana más importante de EuropaAsí lo ha asegurado el miércoles 1 de junio de 2022 el teniente coronel de la Guardia Civil y jefe de la Comandancia de Tarragona, Jordi Verger. La Guardia defiende esta conclusión basándose en que la principal empresa distribuidora de energía eléctrica, recuperó en 2021 hasta 159 millones de kilovatios hora (kWh) de energía procedente de fraudes vinculados a plantaciones cannabis, equivalente al consumo anual de 45 mil hogares, reportó el periódico OK..No te olvides de visitar www.cannabishispano.com suscribirte al podcast y dejar tus comentarios en tu plataforma preferida.Hasta la próxima…//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////Disclaimer Cannabis Hispano no promueve ni participa en actividades ilegales relacionadas con el uso o la venta de marihuana o sus derivados.

Originally published on September 9, 2017. Want to support 'Cotto/Gottfried'? Send the show a monthly contribution! Follow this link and click 'Monthly tip': https://streamlabs.com/cottogottfried/. Your support is greatly appreciated. Like this episode? Donations much appreciated -- no worries about size; it's the thought that counts. Many thanks! https://www.paypal.com/paypalme2/CottoGottfried THERE WILL BE NO MORE 'Cotto/Gottfried' episode uploads in video format. Of course, the show will still hold its usual livestreams on YouTube. Please subscribe to 'C/G' on one (or more -- maybe even all) of the following podcasting platforms ASAP: Apple Podcasts: https://podcasts.apple.com/podcast/id1494171864 Spotify: https://open.spotify.com/show/1X7N1Xw0EstfhuqjAVI6VB Pocket Casts: https://pca.st/rpzzk0z8 Stitcher: https://www.stitcher.com/podcast/anchor-podcasts-provider-2/cottogottfried#/ Breaker: https://www.breaker.audio/cotto-slash-gottfried Google Podcasts: https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy8xMWY0M2IyOC9wb2RjYXN0L3Jzcw== Overcast: https://overcast.fm/itunes1494171864/cotto-gottfried Castbox: https://castbox.fm/channel/Cotto%2FGottfried-id2556945 Anchor: https://anchor.fm/cotto-gottfried Radio Public: https://radiopublic.com/cottogottfried-6VZegX

It's part of just about every cannabis conversation: “Hey, it looks like we’re close to seeing cannabis legalized. Is this the year?”  There are three promising cannabis bills … Read More » The post EP.35: Will Cannabis Legalization, or Safe Banking Pass This Year? appeared first on Insurance Journal TV.

It's part of just about every cannabis conversation: “Hey, it looks like we’re close to seeing cannabis legalized. Is this the year?”  There are three promising cannabis bills … Read More » The post EP.35: Will Cannabis Legalization, or Safe Banking Pass This Year? appeared first on Insurance Journal TV.

It may seem like marijuana laws across the country have been changing almost overnight, but according to our guest, Paul Armentano, deputy director of NORML, a group that has long sought these changes, it’s been about a fifty year process.  We are a long way from ‘Reefer Madness’ and Cheech and Chong, as we see … Continue reading EP 452 Marijuana Laws Changing Across America

CheckIn by GovSight. In this episode, GovSight Reporter Emily Ginas checks in with Deputy Director of the National Organization for the Reform of Marijuana Laws Paul Armentano on where nationwide legalization stands for cannabis, how it is tied to criminal justice reform and the future of the cannabis industry in the United States.

Legal Weed’s Advances and Lawsuits to Overturn Them. Paul Armentano, Deputy Director of NORML, talks about how and why lawsuits have been filed in three of the five states where some form of marijuana was legalized on Nov. 3rd. First the whyArmentano called these lawsuits frivolous attempts to undermine the democratic process. “Since 1996 when California legalized medical marijuana, voters in 35 states have gone to the ballot box to legalize adult-use or medical cannabis. Where they have done that, they’ve been successful. The reality is: when we are given the chance to vote for legal marijuana, we win.” In addition to the unprecedented actions of trying to overturn the will of the voters, opponents of legal marijuana have also tried to kick the issue off the ballot before it even got there. That tactic was unsuccessful in Arizona and unfortunately, it worked in Nebraska.  Sound familiar?Invalidating legally cast ballots after the elections seems to be the tactic de jour of losing opponents. Regardless, Armentano doesn’t think it will work. “They (prohibitionists) have lost the hearts and minds of the American people on this issue. There’s now a supermajority in this country who believe that marijuana should be legal and will continue to vote for it.”The new administration in the White House Vice President-elect Kamala Harris has said the Biden administration would decriminalize marijuana and automatically expunge all marijuana use convictions and incarcerations. Harris has also been the chief sponsor of the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act in the Senate.  Armentano thinks that once cannabis is removed from its Schedule l spot on the DEA’s list of Controlled Substances and dealt with under the jurisdiction of individual states, like alcohol, the incoming Democratic administration will back that sort of cannabis reform…so long as the prohibitionists and obstructionists don’t stand in the way.

Episode 14 of Grow Bud Yourself features as much cannabis and hashish creation information as we can fit into an hour! First, Danny and Mike talk to NORML's Paul Armentano about marijuana politics and policy, descheduling vs. rescheduling cannabis, and drug testing in the weed business (3:40). The interview is with internationally renowned hash-maker The Dank Duchess, who outlines her extraction process for dry sift and fresh frozen full melt hashish and describes her judging procedures to select the world's best cannabis concentrates (18:30). During the cultivation segment, Danny details the different types of cannabis seeds that are available including regular, feminized and auto-flowering seeds, and we answer grow questions from listeners (49:00). Episode 14 is brought to you by Vapor.com. Use code "GBY" for 15% off everything on the site. See acast.com/privacy for privacy and opt-out information.

Marijuana and marijuana policy with Paul Armentano. Paul is the deputy director of the National Organization for the Reform of Marijuana Laws (NORML) and the NORML Foundation in Washington, D.C. Armentano has written on the subject of marijuana and marijuana policy. His work has appeared in over 200 publications, including more than a dozen textbooks and anthologies, and he is a frequent contributor to AlterNet, High Times, The Huffington Post, and the Washington, D.C. newspaper The Hill. Armentano is a 2008 recipient of the 'Project Censored Real News Award for Outstanding Investigative Journalism' and was selected as one of America's 'Top 20 Young Visionaries' by Who Cares Magazine, a national quarterly journal devoted to community service and social activism. He has co-written a book about cannabis and social policies, Marijuana is Safer: So Why Are We Driving People to Drink?, which was published in 2009 through Chelsea Green Publishing.

Flashback to September 2017 on 'The San Francisco Review of Books on Sunday,' the precursor of 'Cotto/Gottfried.' NORML's Twitter page: https://twitter.com/NORML See 'Cotto/Gottfried episodes here: https://www.youtube.com/channel/UC-Pa5w_YWKYQPq-9Haak9gg 'Cotto/Gottfried' on Apple Podcasts: https://podcasts.apple.com/podcast/id1494171864 Check out other podcasting platforms featuring 'Cotto/Gottfried': https://www.youtube.com/watch?v=HrQbk0TjMfY San Francisco Review of Books main page: http://www.sanfranciscoreviewofbooks.com/

Flashback to September 2017 on 'The San Francisco Review of Books on Sunday,' the precursor of 'Cotto/Gottfried.' NORML's Twitter page: https://twitter.com/NORML See 'Cotto/Gottfried episodes here: https://www.youtube.com/channel/UC-Pa5w_YWKYQPq-9Haak9gg 'Cotto/Gottfried' on Apple Podcasts: https://podcasts.apple.com/podcast/id1494171864 Check out other podcasting platforms featuring 'Cotto/Gottfried': https://www.youtube.com/watch?v=HrQbk0TjMfY San Francisco Review of Books main page: http://www.sanfranciscoreviewofbooks.com/

Flashback to September 2017 on 'The San Francisco Review of Books on Sunday,' the precursor of 'Cotto/Gottfried.' NORML's Twitter page: https://twitter.com/NORML See 'Cotto/Gottfried episodes here: https://www.youtube.com/channel/UC-Pa5w_YWKYQPq-9Haak9gg 'Cotto/Gottfried' on Apple Podcasts: https://podcasts.apple.com/podcast/id1494171864 Check out other podcasting platforms featuring 'Cotto/Gottfried': https://www.youtube.com/watch?v=HrQbk0TjMfY San Francisco Review of Books main page: http://www.sanfranciscoreviewofbooks.com/

Flashback to September 2017 on 'The San Francisco Review of Books on Sunday,' the precursor of 'Cotto/Gottfried.' NORML's Twitter page: https://twitter.com/NORML See 'Cotto/Gottfried episodes here: https://www.youtube.com/channel/UC-Pa5w_YWKYQPq-9Haak9gg 'Cotto/Gottfried' on Apple Podcasts: https://podcasts.apple.com/podcast/id1494171864 Check out other podcasting platforms featuring 'Cotto/Gottfried': https://www.youtube.com/watch?v=HrQbk0TjMfY San Francisco Review of Books main page: http://www.sanfranciscoreviewofbooks.com/

Flashback to September 2017 on 'The San Francisco Review of Books on Sunday,' the precursor of 'Cotto/Gottfried.' NORML's Twitter page: https://twitter.com/NORML See 'Cotto/Gottfried episodes here: https://www.youtube.com/channel/UC-Pa5w_YWKYQPq-9Haak9gg 'Cotto/Gottfried' on Apple Podcasts: https://podcasts.apple.com/podcast/id1494171864 Check out other podcasting platforms featuring 'Cotto/Gottfried': https://www.youtube.com/watch?v=HrQbk0TjMfY San Francisco Review of Books main page: http://www.sanfranciscoreviewofbooks.com/

Flashback to September 2017 on 'The San Francisco Review of Books on Sunday,' the precursor of 'Cotto/Gottfried.' NORML's Twitter page: https://twitter.com/NORML See 'Cotto/Gottfried episodes here: https://www.youtube.com/channel/UC-Pa5w_YWKYQPq-9Haak9gg 'Cotto/Gottfried' on Apple Podcasts: https://podcasts.apple.com/podcast/id1494171864 Check out other podcasting platforms featuring 'Cotto/Gottfried': https://www.youtube.com/watch?v=HrQbk0TjMfY San Francisco Review of Books main page: http://www.sanfranciscoreviewofbooks.com/

Green Zone Japan with Naoko Miki and Yuji Masataka. The two of them founded Green Zone Japan as a medical cannabis advocacy group. Its main focus is bringing evidence-based, accurate and up-to-date information on medical cannabis to Japanese medical professionals and the general public. Naoko Miki, Green Zone Japan's Program Director, is a translator by trade. She first became interested in medical cannabis when she translated one of Peter McWilliams' books, "LOVE 101," and learned the circumstances of his death. In 2010, Naoko translated "Marijuana Is Safer" by Mason Tvert, Steve Fox and Paul Armentano (who has been a guest on this show), and created an FB page for the book where she started advocating for legalization in Japan.

See more 'Cotto/Gottfried' episodes here: https://www.youtube.com/channel/UC-Pa5w_YWKYQPq-9Haak9gg/

Deputy Director of NORML Paul Armentano is our guest on this episode of Crime Inc. We talk about many issues surrounding marijuana and marijuana legalization. Some of the issues we talk about are benefits of marijuana legalization, arguments against legalization, history of marijuana as a controlled substance, federal, and state roadblocks to legalization, and many other issues. 

On January 4th, 2018, Attorney General Jeff Sessions rescinded Obama-era policy instructing federal prosecutors not to prioritize prosecutions against violators of federal drug laws in states that had decriminalized marijuana at the state level. This announcement came days after new legalization measures took effect in California. While many states have legalized at the state level, the drug is still illegal everywhere in the United States under federal law. On Lawyer 2 Lawyer, host, Craig Williams joins Paul Armentano, deputy director of NORML and Paul Larkin, senior legal research fellow for the Heritage Foundation's Meese Center for Legal and Judicial Studies, to discuss Attorney General Jeff Sessions' efforts to rescind the Obama-era policies on marijuana, the impact on state’s marijuana legislation, and how this announcement will impact marijuana litigation and the marijuana business. Paul Armentano is deputy director of NORML, the National Organization for the Reform of Marijuana Laws. Paul Larkin is senior legal research fellow for the Heritage Foundation's Meese Center for Legal and Judicial Studies.

NORML (National Organization for the Reform of Marijuana Laws) deputy director Paul Armentano joins PanAm Post English editor David Unsworth for a discussion of Jeff Sessions recent repeal of the Cole Memo, which prohibited the Justice Department from using federal resources to prosecute the production or consumption of marijuana in states that have legalized marijuana. Armentano sees an immediate backlash for the Trump administration, and suggests that Republicans will target state marijuana laws at their own peril. Ultimately, he holds out hope for a bipartisan approach to ending federal marijuana prohibition, noting that polls consistently reveal that voters in both parties are no longer enthusiastic about treating marijuana as a criminal justice matter. Several bills are currently working their way through Congress that seek to end classification of marijuana as a Schedule I drug, and treat marijuana as a public health, not a criminal justice matter. Ultimately, the principles of self-ownership and non-aggression are key to changing the philosophical mentality of politicians on both the left and the right that seek to regulate the behavior of adults in the privacy of their own homes. Americans should be free to make their own decisions for their own lives as long as they do not violate the Constitutional or human rights of others.

Driving under the influence of marijuana: What will the rules and regulations be and what SHOULD they be?  Angela Kokott chats with Paul Armentano, Deputy Director of NORML, the National Organization for the Reform of Marijuana Laws, and also serves as a faculty member at Oaksterdam University.

Will marijuana legalization happen in the south next? Deputy Director of NORML (National Organization for the Reform of Marijuana Laws) Paul Armentano comes to Coastal Noise to talk southern state reform, what legal states are showing us now, shifting public opinion, and what actions southern states can take to end prohibition. Subscribe to Coastal Noise on iTunes, Youtube, Google Play or listen with the included link.   About Paul Armentano: Paul Armentano is the Deputy Director of NORML and faculty member at Oaksterdam Unviversty. His writing and research has appeared in over 750 publications, scholarly and/or peer reviewed journals, as well as more than a dozen textbooks and anthologies. He is a regular contributor to TheHill.com, AlterNet.org, and Freedom Leaf. Mr. Armentano is the co-auothr of "Marijuana is Safer: So Why Are We Driving People to Drink?" which has been licensed and translated internationally. His latest book is called "The Citizen's Guide to State-By-State Marijuana Laws". He is the 2013 Freedom Law School  Health Freedom Champion of the Year and the 2013 Alfred R. Lindesmith award recipient in the achievement in the field of scholarship.             Mr. Armentano was the principal investigator for defense counsel in US vs Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule one controlled substance. He was also an expert in a successful Canadian constitutional challenge (Crown versus Allard) preserving qualified patients' rights to grow cannabis at home. Mr. armentano previously provided online content to the TheAnswerPage.com, an online medical educational resource that provides daily education to healthcare professionals in 120 countries, as well as Continuing Medical Education credit. A version of this curriculum is now required in New York state for any physician who wishes to participate in the state's medical cannabis program.   About NORML: The National Organization for the Reform of Marijuana Laws. Since its founding in 1970, NORML has provided a voice in the public policy debate for those Americans who oppose marijuana prohibition and favor an end to the practice of arresting marijuana smokers. A nonprofit public-interest advocacy group, NORML represents the interests of the tens of millions of Americans who smoke marijuana responsibly. NORML's mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high quality marijuana that is safe, convenient and affordable. (Fyi : NORML has a great newsletter that I have been subscribed to for almost ten years. Check it out.)   Show Notes:   -Marijuana in the main stream (over half of the US polling YES for legalization)   -What we're learning from legal states - - - "We have not seen [in the 30 states] that have enacted marijuana laws, starting with California in 1996...not a single one of those states has ever gone back and recriminalized marijuana."   -Lack of uptick in use with young teens or access in jurisdictions where marijuana is regulated.   -Paul Armentano Video Lecture : "Facts vs. Fears : Countering Common Misconceptions about Medicinal Cannabis" - - - "The most frustrating aspect of marijuana policy in America [at the federal level] is we do not have an evidence based policy...[it is] 180 degrees removed from what relevant science is telling us."   -Using PubMed to research Marijuana - - - "Outside of tabbaco, marijuana is the most studied plant on Earth...[there is] nearly 26,000 individual, peer reviewed studies of marijuana...That is more than twice the volume of literature dedicated to Ibeprofin...It's more than 20 times the available literature to hydrocodone."   -"We have a long history of human use than we have conventional substances we consume everyday...The problem isn't we don't know enough about cannabis, [it's that] we have public policies that are divorced from what the available science tells us."   -The Ole Miss Federal Marijuana Farm and how it is used for clinical research across the country   -The Compassionate Investigational New Drug Program of 1978 and the patients who receive 300 rolled marijuana cigarettes a month from the US Government & what studies on these patients tell us.   -Why was marijuana originally made illegal?   -Creating change where prohibition still exists   Hosted by Stefan Lawson. 8/8/17   Please subscribe, share, leave reviews, or comments. We would love to hear your feedback.   Subscribe on iTunes here     Subscribe on Youtube here

As the High Holiday of the Cannabis Calendar (4/20!) is upon us, Dr. Kelly invites NORMLs Deputy Director Paul Armentano to share with us his thoughts on the current state of cannabis legalization, policy and scientific efficacy in the US in 2017! What does this year hold for legal cannabis in America? Remember that 4-19 is Take Action Day for cannabis reform day, and you can find out more here: norml.org/act While more Americans than ever before favor the legalization of both recreational and medical cannabis, and over 30 states currently have legal medical dispensary systems, cannabis remains firmly on the DEAs Federal Schedule 1, classified to have no accepted medical value. Adding to this confusion is our new President and Attorney General offering confusing messages about the plant, and about federal involvement in state sanctioned marijuana programs. Today, Mr. Armentano addresses what he describes as the ignorance and political apathy on the part of lawmakers, and political inertia that continues to maintain this flat earth policy regarding federal legalization and scheduling. But what does the science and research really show? Mr. Armentano shares with Dr. Kelly today some of the common misconceptions about cannabis, as well on going research on its public health benefits (including helping curb the opiate epidemic). We also discuss a recent literature review of over 10,000 studies on cannabis shows its efficacy in treating conditions like chronic pain, nausea, epilepsy, MS and more. In this interview, we address the political climate including: What does this new administration hold for cannabis legalization over the next year? What is the current federal legality of CBDs? Will the office of drug czar be abolished? Will state mandated cannabis programs be subject to federal law? Will cannabis ever be removed from Schedule 1, and what will it take for this to happen? How can people get involved at state and federal levels to let their voice be heard? Paul Armentano is the Deputy Director of NORML, the National Organization for the Reform of Marijuana Laws, and also serves as a faculty member at Oaksterdam University. His writing and research have appeared in over 750 publications, scholarly and/or peer-reviewed journals, as well as in more than a dozen textbooks and anthologies. He is a regulator contributor to TheHill.com as well as to numerous other print and online publications, including Freedom Leaf and Alternet.org. Mr. Armentano is the co-author of the book Marijuana is Safer: So Why Are We Driving People to Drink? which has been licensed and translated internationally. His most recent book, The Citizens Guide to State-By-State Marijuana Laws (2015), is available from Whitman Publishing.

Listen NowThis past November, voters in seven states legalized marijuana either for medical or for recreational use.  Twenty-nine states have now legalized cannabis for medicinal use (and of these eight, along with the District of Columbia, for recreational use).   Despite growing state legalization, the debate concerning marijuana's health effects continues.  Recently, the National Academy of Sciences (NAS) published an extensive scientific review of research literature published since 1999 to reach nearly 100 conclusions about its therapeutic benefits including in the treatment for chronic pain in adults, chemotherapy-related nausea and vomiting and Multiple Sclerosis-related spasticity.  Despite state approval and demonstrated health benefits, at the federal level, marijuana is still classified as a Schedule I controlled substance (along with, e.g., heroin), and its use illegal.  Mr. Paul Armentano is the Deputy Director of NORML, the National Organization for the Reform of Marijuana Laws.  He is also a faculty member at Oaksterdam University in Oakland, California.  His is the author of over 200 publications including more than a dozen contributions to textbooks and anthologies.  His most recent book-length work is, The Citizen's Guide to State-by-State Marijuana Laws (2015) and he is co-author of the 2013 volume, Marijuana is Safer: Why Are We Driving People to Drink?  Mr. Armentano was the principle investigator for the defense counsel in US v Schweder, the first federal evidentiary hearing since 1973 to challenge the constitutionality of cannabis as a Schedule I controlled substance.  He also served as an expert in a successful Canadian constitutional challenge, Crown v. Allard, preserving qualified patients right to grow cannabis at home.   Among other awards Mr. Armentano was the 2013 Freedom Law School Health Freedom Champion of the Year.  The National Academy of Sciences' report, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research is at: http://nationalacademies.org/hmd/reports/2017/health-effects-of-cannabis-and-cannabinoids.aspx.For more information regarding NORML go to: http://norml.org/. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

In a recent decision, the Drug Enforcement Administration ruled that marijuana will remain a Schedule 1 substance under the Controlled Substances Act. Substances in Schedule 1 are determined by the Food and Drug Administration to be drugs with no currently accepted medical use and a high potential for abuse.   On Lawyer 2 Lawyer, host J. Craig Williams joins Paul Armentano, deputy director of NORML and Ben Cort, business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), to discuss the recent decision by the DEA to keep marijuana on the Schedule 1 list. They will talk impact, the legalization of marijuana, manufacturing marijuana for scientific purposes, and what the future holds on this controversial topic. Paul Armentano is deputy director of NORML, and the National Organization for the Reform of Marijuana Laws, and a senior policy advisor at Freedom Leaf, Inc: The Marijuana Legalization Company. He is the co-author of the book “Marijuana is Safer: So Why Are We Driving People to Drink?” Paul was also the principal investigator for defense counsel in U.S. v Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule I controlled substance. Ben Cort is business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), part of the University of Colorado Health system. Ben’s passion for recovery, prevention and harm reduction comes from his own struggle with substance abuse. Sober since 1996, Cort is also a junior fellow at the University of Florida’s Drug Policy Institute and serves on the boards of Project SAM (Smart Approaches to Marijuana) and the Stout Street Foundation. Special thanks to our sponsor, Clio.

Paul Armentano is the Deputy Director of NORML and the NORML Foundation. Mr. Armentano is an expert in the field of marijuana policy, health, and pharmacology, and has served as a consultant for Health Canada and the Canadian Public Health Association. He has spoken at numerous national conferences and legal seminars, testified before state legislatures and federal agencies, and assisted dozens of criminal defense attorneys in cases pertaining to the use of medicinal cannabis, drug testing, and drugged driving. He is a frequent guest on radio, and has appeared frequently on the nationally syndicated Dr. Drew Pinsky show. Mr. Armentano is a prolific writer on the subject of marijuana and marijuana policy. His work has appeared in over 500 publications, including the New York Times, Washington Post, and The Christian Science Monitor. His writing has been featured in more than a dozen textbooks and anthologies, and he is a frequent contributor to AlterNet, High Times, The Huffington Post, and the Washington, D.C. newspaper The Hill. Mr. Armentano is a 2008 recipient of the 'Project Censored Real News Award for Outstanding Investigative Journalism,' and is the co-author of the book Marijuana is Safer: So Why Are We Driving People to Drink? (2009, Chelsea Green). He lives in northern California and is a frequent speaker at Oaksterdam University in Oakland.

Selected clips from presenters at Day 1 of the NORML Aspen Legal Seminar, featuring Paul Armentano, Sheriff Joe DiSalvo, Pat Oglesby, Courtney Moran, more.

Dr. Mich Earleywine talks with Paul Armentano, Deputy Director of NORML, about effects before and after the consumption of cannabis. Mitch and Paul discuss the effects THC has on motor skills and the use of cannabis before driving, moving on to compare it with drinking and driving.

Recently reports proliferated that in the House of Representatives, during the government shutdown, while meeting late into the night, the smell of booze was rampant.  Perhaps if they had been smoking pot, instead of drinking alcohol, the government would never have been shut down and there might be a whiff more bipartisanship.Sound ridiculous? Well if it had been the Colorado or Washington legislature, it might very well be the case.  In fact the legalization of marijuana seems to be an idea whose time has come. Recent votes in Colorado and Washington, coupled with the twenty states already allowing medical marijuana, and the decision by the Justice Department to rescind prosecutions, are all key sign posts along the way.A key player in this effort, who was also instrumental in Colorado's recent decision to legalize even recreational use, is Paul Armentano.  He's the co-author of Marijuana is Safer: So Why Are We Driving People to Drink? My conversation with Paul Armentano:

In this week's podcast, Paul Armentano, Deputy Director of NORML discusses the unconstitutional nature of the war on marijuana, the history of marijuana prohibition in the U.S., the commerce clause as a federal excuse to regulate and prohibit various activities and more.